Evidence map›Paper›PMID 39351062›Full record

ArticleFrontiers in bioengineering and biotechnology2024

GenoMine: a CRISPR-Cas9-based kill switch for biocontainment of

Enrique Asin-Garcia, Maria Martin-Pascual, Claudia de Buck, Max Allewijn, Alexandra Müller, Vitor A P Martins Dos Santos

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Beyond the Usual Suspects: EmergingInternational journal of molecular sciences · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. EngineeringAIMS microbiology · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. AFrontiers in systems biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Enrique Asin-GarciaLaboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, Netherlands.
Maria Martin-PascualLaboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, Netherlands.
Claudia de BuckLaboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, Netherlands.
Max AllewijnLaboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, Netherlands.
Alexandra MüllerLaboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, Netherlands.
Vitor A P Martins Dos SantosLaboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthetic genetic circuits have revolutionised our capacity to control cell viability by conferring microorganisms with programmable functionalities to limit survival to specific environmental conditions. Here, we present the GenoMine safeguard, a CRISPR-Cas9-based kill switch for the biotechnological workhorse

Indexed as

CRISPR-Cas9-mediated biocontainmentgenetic circuitkill switchP. putidariboregulator

Identifiers

PMID39351062
PMCPMC11439788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.